RECRUITING

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.

Official Title

Clinical Testing of Near Infrared Spectroscopy (NIRS) for Quantitative Assessment of Depression

Quick Facts

Study Start:2019-01-04
Study Completion:2026-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04061148

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All subjects who sign informed consent.
  2. * Controls: Volunteers over 18 years of age who are not depressed.
  3. * Patients over 18 years of age with a diagnosis of Major Depressive Disorder, receiving clinical therapy at SFVAMC.
  1. * Subjects who cannot sign informed consent.
  2. * Exclusion criteria for control subjects: 1.Depression 2.Anxiety, psychotic, substance abuse, mood and personality disorders 3.Major neurocognitive disorders such as Alzheimer's disease and other dementias 4.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation
  3. * Exclusion criteria for depressed patients: 1.Psychotic disorders like schizophrenia 2.Major neurocognitive disorders such as Alzheimer's disease and other dementias 3.Neurologic disorders with anatomic lesions including traumatic brain injury, stroke, tumor and arteriovenous malformation 4.Not receiving clinical therapy for depression at SFVAMC'

Contacts and Locations

Study Contact

Anusha Badathala, MBBS
CONTACT
4152214810
Anusha.Badathala@ncire.org
Arthur Wallace, MD, PhD
CONTACT
4152214810
art.wallace@va.gov

Principal Investigator

Arthur Wallace, MD, PhD
PRINCIPAL_INVESTIGATOR
San Francisco Veterans Affairs Medical Center

Study Locations (Sites)

San Francisco Veterans Affairs Medical Center
San Francisco, California, 94121
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Arthur Wallace, MD, PhD, PRINCIPAL_INVESTIGATOR, San Francisco Veterans Affairs Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-01-04
Study Completion Date2026-12-30

Study Record Updates

Study Start Date2019-01-04
Study Completion Date2026-12-30

Terms related to this study

Keywords Provided by Researchers

  • Near Infrared Spectroscopy
  • Depression
  • NIRS
  • Major Depressive Disorder

Additional Relevant MeSH Terms

  • Major Depressive Disorder